Ganirelix acetate

13(S)-HODE is the LO metabolite of linoleic acid. 13(S)-HODE modulates the PAF, LTB4, and fMLP-induced calcium influx in human PMNL.

CAS No.: 591-17-3 UN No.: UN1993 Solubility: 0.05 g/l Melting Point: -40°C Molar Mass: 171.03 g/mol Boiling Point: 184°C Vapor Pressure: 2.04 hPa (25°C) Flash Point: 60°C Refractive Index: 60°C Density: 1.405 g/cm3 (20°C

CAS No.: 591-17-3 UN No.: UN1993 Solubility: 0.05 g/l Melting Point: -40°C Molar Mass: 171.03 g/mol Boiling Point: 184°C Vapor Pressure: 2.04 hPa (25°C) Flash Point: 60°C Refractive Index: 60°C Density: 1.405 g/cm3 (20°C

5-Bromopentyl acetate

7-Bromotetralone is a synthetic intermediate useful for pharmaceutical synthesis.

Abarelix acetate is a synthetic peptide gonadotropin releasing hormone receptor (GnRH) antagonist.

Abarelix acetate is a synthetic peptide gonadotropin releasing hormone receptor (GnRH) antagonist.

Abarelix acetate is a synthetic peptide gonadotropin releasing hormone receptor (GnRH) antagonist.

ApplicationAH6809 has been used:as a prostaglandin E2 receptor 1 &amp: 2 (EP1/2) antagonist to analyze its effects on cyclooxygenase-2 /prostaglandin E2 (COX-2/PGE2) signaling in the angiogenic feedback of endothelial cells to hypoxiaas an EP2

A potent, allosteric inhibitor of Akt1 and Akt2 (IC₅₀ = 58 and 210 nM, respectively) that less effectively blocks Akt3 activity (IC₅₀ = 2.2 &microM) cell permeable, blocking insulin regulation of FOXO1 activity at 1 &microM

A potent, allosteric inhibitor of Akt1 and Akt2 (IC₅₀ = 58 and 210 nM, respectively) that less effectively blocks Akt3 activity (IC₅₀ = 2.2 &microM) cell permeable, blocking insulin regulation of FOXO1 activity at 1 &microM

This nuclear receptor assay system utilizes proprietary non-human mammalian cells engineered to provide constitutive, high-level expression of full-length, unmodified human androgen receptor (NR3C4), a ligand-dependent transcription factor commonly